Pfizer’s next play: A vaccine maker and pandemic ‘partner’ to governments
May 04, 2021 at 15:00 PM EDT
Pfizer Inc.’s COVID-19 vaccine is on track to generate a whopping $26 billion in sales this year, making it the drug maker’s top-selling drug and forging a new path into infectious diseases for the legacy drug maker.
